<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Virgin Islands, U.S.</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Virgin Islands, U.S..</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/vi.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Sat, 07 Nov 2026 03:45:11 GMT</lastBuildDate>
  <item>
    <title>Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1038-s41586-021-04385-3-fbbb1af2/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1038-s41586-021-04385-3-fbbb1af2/</guid>
    <pubDate>Thu, 23 Dec 2021 00:00:00 GMT</pubDate>
    <description>The findings are relevant to antibody-based medicine and vaccine development because Omicron escaped a large proportion of the tested neutralizing antibodies. The authors report that antibodies targeting conserved sarbecovirus regions remained most effective in their experiments and state that the results may inform countermeasure development for Omicron and future variants.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
